N-[4-methyl-1-[[(2S)-1-[[4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]amino]-1-oxopentan-2-yl]-5-(morpholin-4-ylmethyl)-1,2-oxazole-3-carboxamide
C30H44N6O7S — CID 130371033
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-methyl-1-[[(2S)-1-[[4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]amino]-1-oxopentan-2-yl]-5-(morpholin-4-ylmethyl)-1,2-oxazole-3-carboxamide
N-[4-methyl-1-[[(2S)-1-[[4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]amino]-1-oxopentan-2-yl]-5-(morpholin-4-ylmethyl)-1,2-oxazole-3-carboxamide (PubChem CID 130371033) has the molecular formula C30H44N6O7S and a molecular weight of 632.78 g/mol. Its IUPAC name is N-[4-methyl-1-[[(2S)-1-[[4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]amino]-1-oxopentan-2-yl]-5-(morpholin-4-ylmethyl)-1,2-oxazole-3-carboxamide.
Molecular Properties
| Compound Name | N-[4-methyl-1-[[(2S)-1-[[4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]amino]-1-oxopentan-2-yl]-5-(morpholin-4-ylmethyl)-1,2-oxazole-3-carboxamide |
|---|---|
| PubChem CID | 130371033 |
| Molecular Formula | C30H44N6O7S |
| Molecular Weight | 632.78 g/mol |
| Exact Mass | 632.30 |
| IUPAC Name | N-[4-methyl-1-[[(2S)-1-[[4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]amino]-1-oxopentan-2-yl]-5-(morpholin-4-ylmethyl)-1,2-oxazole-3-carboxamide |
| SMILES | CC(C)CC(NC(=O)c1cc(CN2CCOCC2)on1)C(=O)N[C@@H](Cc1cscn1)C(=O)NC(CC(C)C)C(=O)[C@@]1(C)CO1 |
| InChI | InChI=1S/C30H44N6O7S/c1-18(2)10-22(26(37)30(5)16-42-30)32-28(39)24(12-20-15-44-17-31-20)34-27(38)23(11-19(3)4)33-29(40)25-13-21(43-35-25)14-36-6-8-41-9-7-36/h13,15,17-19,22-24H,6-12,14,16H2,1-5H3,(H,32,39)(H,33,40)(H,34,38)/t22?,23?,24-,30+/m0/s1 |
| InChIKey | FGCJQORTUAJPJC-JYFNXRQWSA-N |
| XLogP | 1.72 |
| TPSA | 168.29 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 632.78 |
| LogP ≤ 5 | 1.72 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130371033 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.